Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Second-Line Low-Dose Cytarabine after First-Line Treatment with 5-Azacitidine in Elderly Patients with AML or High-Risk MDS Ineligible for Intensive Chemotherapy. A Retrospective Single Center Analysis

Christian Jakob, MD, Benjamin Gunther, MD, Katharina Dittberner, MD, Leonard Boger, MD, Philipp Bleienheuft, MD, Frank Breywisch, MD, Frank Rothmann, MD, Stefan Peinert, MD, Georg Maschmeyer, MD

Blood (2015) 126 (23): 3780.

https://doi.org/10.1182/blood.V126.23.3780.3780

Published: 2015

Journal Articles

Autologous Peripheral Blood T Lymphocytes Transduced with An Anti LewisY Chimeric Receptor Gene Persist In Patients with Lewis y Positive Acute Myeloid Leukaemia and Show Changes In Functional Polarization After Adoptive Transfer,

Paul Neeson, PhD, Amit S Khot, MBBS, MD, MRCP, FRCPath, Stefan Peinert, MD, Tsin Y Tai, MSc, Karen Chen, Kellie Tainton, BSc, Dominic Wall, PhD, Dirk Hoenemann, MD, Michael H Kershaw, PhD, Jennifer Westwood, Joe Trapani, PhD, Mark J Smyth, PhD, Phillip Darcy, PhD, Andrew Scott, PhD, Lucy Kravets, BSc, Jill Davison, RN, Michael J. Dickinson, MBBS, FRACP, FRCPA, David Ritchie, MBBS, FRACP, FRCPA, PhD, Miles Prince, MD, FRACP, FRCPA

Blood (2011) 118 (21): 4180.

https://doi.org/10.1182/blood.V118.21.4180.4180

Published: 2011

Journal Articles

Fludarabine Based Combinations Are Highly Effective as First-Line or Salvage Treatment in Patients with Waldenström Macroglobulinemia

Stefan Peinert, Constantine Tam, H. Miles Prince, Max M. Wolf, E. Henry Januszewicz, David Westerman, John D. Scarlett, John F. Seymour

Blood (2008) 112 (11): 4947.

https://doi.org/10.1182/blood.V112.11.4947.4947

Published: 2008

Journal Articles

Complete Remission on 18F-FDG-PET Prior to Autologous Stem Cell Transplantation Predicts Superior Event Free Survival of Patients with Relapsed or Refractory Hodgkin Lymphoma.

Stefan Peinert, Rosemary Hoyt, Jeffrey Szer, John F. Seymour, H. Miles Prince, Andrew W Roberts, Luigi Rigacci, Andrew Grigg, David S. Ritchie

Blood (2008) 112 (11): 2188.

https://doi.org/10.1182/blood.V112.11.2188.2188

Published: 2008

Journal Articles

Targeting Lewis Y-Positive Multiple Myeloma and Acute Myeloid Leukemia with Gene-Modified T Cells Demonstrating Memory Phenotype

Stefan Peinert, David S. Ritchie, Dirk Hoenemann, Simon J. Harrison, Preethi Guru, Michael H. Kershaw, Amanda Shin, Mark J. Smyth, Joseph A. Trapani, Andrew M Scott, Glenn A Cartwright, Fiona E Smyth, Barbara E Power, Phillip K. Darcy, Peter Gambell, David Westerman, Paul Neeson, H. Miles Prince

Blood (2008) 112 (11): 3900.

https://doi.org/10.1182/blood.V112.11.3900.3900

Published: 2008

Journal Articles

Gene-Modified CD8+ T Cells Undergo Functional Polarization to Effector and Central Memory Cells in Response to Antigen Exposure.

Paul Neeson, PhD, Amanda Shin, Tsin Tai, MSc, Karen Chen, Joanne Davis, Kellie Tainton, BSc, Phil Darcy, PhD, Michael H. Kershaw, Stefan Peinert, Preethi Guru, Simon Harrison, H. Miles Prince, D. Ritchie

Blood (2008) 112 (11): 1531.

https://doi.org/10.1182/blood.V112.11.1531.1531

Published: 2008

Journal Articles

Low Predictive Value of Functional Imaging with 18 FDG-PET or Gallium Scanning in Relapsed or Refractory Hodgkin Lymphoma Prior to Autologous Stem Cell Transplantation.

Stefan Peinert, MD, Rosemary Hoyt, MD, Jeff Szer, MD, Andrew Roberts, MD, Andrew Grigg, MD, H. Miles Prince, MD, Luigi Rigacci, MD, John F. Seymour, MD, David S. Ritchie, MD

Blood (2007) 110 (11): 5127.

https://doi.org/10.1182/blood.V110.11.5127.5127

Published: 2007

Journal Articles

Safety and Efficacy of the Combination of Bortezomib with the Deacetylase Inhibitor Romidepsin in Patients with Relapsed or Refractory Multiple Myeloma: Preliminary Results of a Phase I Trial.

Miles Prince, MBBS, Hang Quach, MBBS, Paul Neeson, MBBS, Mitch Keegan, Michael Copeman, MBBS, Stefan Peinert, MBBS, Mark Bishton, MBBS, Max Wolf, MBBS, David Ritchie, MBBS, John F. Seymour, MBBS, Dennis Carney, MBBS, David Westerman, MBBS, Simon Harrison, MBBS

Blood (2007) 110 (11): 1167.

https://doi.org/10.1182/blood.V110.11.1167.1167

Published: 2007

NARROW

Second-Line Low-Dose Cytarabine after First-Line Treatment with 5-Azacitidine in Elderly Patients with AML or High-Risk MDS Ineligible for Intensive Chemotherapy. A Retrospective Single Center Analysis

Autologous Peripheral Blood T Lymphocytes Transduced with An Anti LewisY Chimeric Receptor Gene Persist In Patients with Lewis y Positive Acute Myeloid Leukaemia and Show Changes In Functional Polarization After Adoptive Transfer,

Fludarabine Based Combinations Are Highly Effective as First-Line or Salvage Treatment in Patients with Waldenström Macroglobulinemia

Complete Remission on 18F-FDG-PET Prior to Autologous Stem Cell Transplantation Predicts Superior Event Free Survival of Patients with Relapsed or Refractory Hodgkin Lymphoma.

Targeting Lewis Y-Positive Multiple Myeloma and Acute Myeloid Leukemia with Gene-Modified T Cells Demonstrating Memory Phenotype

Gene-Modified CD8+ T Cells Undergo Functional Polarization to Effector and Central Memory Cells in Response to Antigen Exposure.

Low Predictive Value of Functional Imaging with 18 FDG-PET or Gallium Scanning in Relapsed or Refractory Hodgkin Lymphoma Prior to Autologous Stem Cell Transplantation.

Safety and Efficacy of the Combination of Bortezomib with the Deacetylase Inhibitor Romidepsin in Patients with Relapsed or Refractory Multiple Myeloma: Preliminary Results of a Phase I Trial.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only